You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动丨维亚生物(1873.HK)大涨逾9% 与百图生科达成战略合作 推动创新药物研发
格隆汇 05-17 14:16
格隆汇5月17日丨维亚生物(1873.HK)午后涨幅扩大至9.23%,报7.1港元,成交额放大至8145万港元,总市值137亿港元。维亚生物日前公布,与百图生科签署战略合作协议,将基于百图生科的AI+生物计算引擎,与公司基于结构的综合性新药发现平台形成技术互补,共同加速推进生物创新药物研发设计。百图生科由百度创始人李彦宏发起创立,致力通过先进AI技术及前沿生物技术的融合创新,加速新型药物和诊断产品的研发。光大证券此前表示,公司的EFS业务进入收获期,确定性和稳定性逐渐增强,维持“买入”评级。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account